 | • レポートコード：D0804-08951 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、神経遮断薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。神経遮断薬の種類別市場規模（第一世代、第二世代、第三世代）、用途別市場規模（統合失調症、双極性障害、単極性うつ病、認知症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Johnson & Johnson、Bristol-Myers Squibb、Pfizer、Allergan、Eli Lilly、GSK、AstraZeneca ・地域別グローバル市場分析 2015年-2020年 ・神経遮断薬の北米市場（アメリカ、カナダ、メキシコ） ・神経遮断薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・神経遮断薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・神経遮断薬の南米市場（ブラジル、アルゼンチン） ・神経遮断薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：第一世代、第二世代、第三世代 ・用途別分析：統合失調症、双極性障害、単極性うつ病、認知症、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Neuroleptics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Neuroleptics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Neuroleptics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neuroleptics market has been segmented into
First Generation
Second Generation
Third Generation
By Application, Neuroleptics has been segmented into:
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neuroleptics market presented in the report. This section sheds light on the sales growth of different regional and country-level Neuroleptics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neuroleptics market.
The report offers in-depth assessment of the growth and other aspects of the Neuroleptics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Neuroleptics Market Share Analysis
Neuroleptics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neuroleptics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neuroleptics sales, revenue and market share for each player covered in this report.
The major players covered in Neuroleptics are:
Johnson & Johnson
Bristol-Myers Squibb
Pfizer
Allergan
Eli Lilly
GSK
AstraZeneca
Among other players domestic and global, Neuroleptics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuroleptics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuroleptics, with price, sales, revenue and global market share of Neuroleptics in 2018 and 2019.
Chapter 3, the Neuroleptics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuroleptics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neuroleptics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neuroleptics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Neuroleptics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuroleptics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 First Generation
1.2.3 Second Generation
1.2.4 Third Generation
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuroleptics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Schizophrenia
1.3.3 Bipolar Disorder
1.3.4 Unipolar Depression
1.3.5 Dementia
1.3.6 Others
1.4 Overview of Global Neuroleptics Market
1.4.1 Global Neuroleptics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Johnson & Johnson SWOT Analysis
2.1.4 Johnson & Johnson Product and Services
2.1.5 Johnson & Johnson Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb SWOT Analysis
2.2.4 Bristol-Myers Squibb Product and Services
2.2.5 Bristol-Myers Squibb Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Allergan SWOT Analysis
2.4.4 Allergan Product and Services
2.4.5 Allergan Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GSK SWOT Analysis
2.6.4 GSK Product and Services
2.6.5 GSK Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AstraZeneca SWOT Analysis
2.7.4 AstraZeneca Product and Services
2.7.5 AstraZeneca Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neuroleptics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neuroleptics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neuroleptics Manufacturer Market Share in 2019
3.3.2 Top 6 Neuroleptics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neuroleptics Sales, Revenue and Market Share by Regions
4.1.1 Global Neuroleptics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neuroleptics Revenue and Market Share by Regions (2015-2020)
4.2 North America Neuroleptics Sales and Growth Rate (2015-2020)
4.3 Europe Neuroleptics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neuroleptics Sales and Growth Rate (2015-2020)
4.5 South America Neuroleptics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neuroleptics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neuroleptics Sales, Revenue and Market Share by Country
5.1.1 North America Neuroleptics Sales and Market Share by Country (2015-2020)
5.1.2 North America Neuroleptics Revenue and Market Share by Country (2015-2020)
5.2 United States Neuroleptics Sales and Growth Rate (2015-2020)
5.3 Canada Neuroleptics Sales and Growth Rate (2015-2020)
5.4 Mexico Neuroleptics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neuroleptics Sales, Revenue and Market Share by Country
6.1.1 Europe Neuroleptics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neuroleptics Revenue and Market Share by Country (2015-2020)
6.2 Germany Neuroleptics Sales and Growth Rate (2015-2020)
6.3 UK Neuroleptics Sales and Growth Rate (2015-2020)
6.4 France Neuroleptics Sales and Growth Rate (2015-2020)
6.5 Russia Neuroleptics Sales and Growth Rate (2015-2020)
6.6 Italy Neuroleptics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neuroleptics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neuroleptics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neuroleptics Revenue and Market Share by Regions (2015-2020)
7.2 China Neuroleptics Sales and Growth Rate (2015-2020)
7.3 Japan Neuroleptics Sales and Growth Rate (2015-2020)
7.4 Korea Neuroleptics Sales and Growth Rate (2015-2020)
7.5 India Neuroleptics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neuroleptics Sales and Growth Rate (2015-2020)
7.7 Australia Neuroleptics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neuroleptics Sales, Revenue and Market Share by Country
8.1.1 South America Neuroleptics Sales and Market Share by Country (2015-2020)
8.1.2 South America Neuroleptics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neuroleptics Sales and Growth Rate (2015-2020)
8.3 Argentina Neuroleptics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neuroleptics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neuroleptics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neuroleptics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neuroleptics Sales and Growth Rate (2015-2020)
9.3 Turkey Neuroleptics Sales and Growth Rate (2015-2020)
9.4 Egypt Neuroleptics Sales and Growth Rate (2015-2020)
9.5 South Africa Neuroleptics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neuroleptics Sales and Market Share by Type (2015-2020)
10.2 Global Neuroleptics Revenue and Market Share by Type (2015-2020)
10.3 Global Neuroleptics Price by Type (2015-2020)
11 Global Neuroleptics Market Segment by Application
11.1 Global Neuroleptics Sales Market Share by Application (2015-2020)
11.2 Global Neuroleptics Revenue Market Share by Application (2015-2020)
11.3 Global Neuroleptics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neuroleptics Sales, Revenue and Growth Rate (2021-2025)
12.2 Neuroleptics Market Forecast by Regions (2021-2025)
12.2.1 North America Neuroleptics Market Forecast (2021-2025)
12.2.2 Europe Neuroleptics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neuroleptics Market Forecast (2021-2025)
12.2.4 South America Neuroleptics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neuroleptics Market Forecast (2021-2025)
12.3 Neuroleptics Market Forecast by Type (2021-2025)
12.3.1 Global Neuroleptics Sales Forecast by Type (2021-2025)
12.3.2 Global Neuroleptics Market Share Forecast by Type (2021-2025)
12.4 Neuroleptics Market Forecast by Application (2021-2025)
12.4.1 Global Neuroleptics Sales Forecast by Application (2021-2025)
12.4.2 Global Neuroleptics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Neuroleptics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neuroleptics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neuroleptics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Neuroleptics Major Business
Table 9. Johnson & Johnson Neuroleptics Total Revenue (USD Million) (2017-2018)
Table 10. Johnson & Johnson SWOT Analysis
Table 11. Johnson & Johnson Neuroleptics Product and Services
Table 12. Johnson & Johnson Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb Neuroleptics Major Business
Table 15. Bristol-Myers Squibb Neuroleptics Total Revenue (USD Million) (2017-2018)
Table 16. Bristol-Myers Squibb SWOT Analysis
Table 17. Bristol-Myers Squibb Neuroleptics Product and Services
Table 18. Bristol-Myers Squibb Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Neuroleptics Major Business
Table 21. Pfizer Neuroleptics Total Revenue (USD Million) (2017-2018)
Table 22. Pfizer SWOT Analysis
Table 23. Pfizer Neuroleptics Product and Services
Table 24. Pfizer Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Allergan Basic Information, Manufacturing Base and Competitors
Table 26. Allergan Neuroleptics Major Business
Table 27. Allergan Neuroleptics Total Revenue (USD Million) (2017-2018)
Table 28. Allergan SWOT Analysis
Table 29. Allergan Neuroleptics Product and Services
Table 30. Allergan Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly Neuroleptics Major Business
Table 33. Eli Lilly Neuroleptics Total Revenue (USD Million) (2017-2018)
Table 34. Eli Lilly SWOT Analysis
Table 35. Eli Lilly Neuroleptics Product and Services
Table 36. Eli Lilly Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GSK Basic Information, Manufacturing Base and Competitors
Table 38. GSK Neuroleptics Major Business
Table 39. GSK Neuroleptics Total Revenue (USD Million) (2017-2018)
Table 40. GSK SWOT Analysis
Table 41. GSK Neuroleptics Product and Services
Table 42. GSK Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Neuroleptics Major Business
Table 45. AstraZeneca Neuroleptics Total Revenue (USD Million) (2017-2018)
Table 46. AstraZeneca SWOT Analysis
Table 47. AstraZeneca Neuroleptics Product and Services
Table 48. AstraZeneca Neuroleptics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Neuroleptics Sales by Manufacturer (2018-2019) (K MT)
Table 50. Global Neuroleptics Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Neuroleptics Sales by Regions (2015-2020) (K MT)
Table 52. Global Neuroleptics Sales Market Share by Regions (2015-2020)
Table 53. Global Neuroleptics Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Neuroleptics Sales by Countries (2015-2020) (K MT)
Table 55. North America Neuroleptics Sales Market Share by Countries (2015-2020)
Table 56. North America Neuroleptics Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Neuroleptics Revenue Market Share by Countries (2015-2020)
Table 58. Europe Neuroleptics Sales by Countries (2015-2020) (K MT)
Table 59. Europe Neuroleptics Sales Market Share by Countries (2015-2020)
Table 60. Europe Neuroleptics Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Neuroleptics Sales by Regions (2015-2020) (K MT)
Table 62. Asia-Pacific Neuroleptics Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Neuroleptics Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Neuroleptics Sales by Countries (2015-2020) (K MT)
Table 65. South America Neuroleptics Sales Market Share by Countries (2015-2020)
Table 66. South America Neuroleptics Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Neuroleptics Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Neuroleptics Sales by Countries (2015-2020) (K MT)
Table 69. Middle East & Africa Neuroleptics Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Neuroleptics Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Neuroleptics Revenue Market Share by Countries (2015-2020)
Table 72. Global Neuroleptics Sales by Type (2015-2020) (K MT)
Table 73. Global Neuroleptics Sales Share by Type (2015-2020)
Table 74. Global Neuroleptics Revenue by Type (2015-2020) (USD Million)
Table 75. Global Neuroleptics Revenue Share by Type (2015-2020)
Table 76. Global Neuroleptics Sales by Application (2015-2020) (K MT)
Table 77. Global Neuroleptics Sales Share by Application (2015-2020)
Table 78. Global Neuroleptics Sales Forecast by Regions (2021-2025) (K MT)
Table 79. Global Neuroleptics Market Share Forecast by Regions (2021-2025)
Table 80. Global Neuroleptics Sales Forecast by Type (2021-2025) (K MT)
Table 81. Global Neuroleptics Market Share Forecast by Type (2021-2025)
Table 82. Global Neuroleptics Sales Forecast by Application (2021-2025)
Table 83. Global Neuroleptics Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neuroleptics Picture
Figure 2. Global Sales Market Share of Neuroleptics by Type in 2019
Figure 3. First Generation Picture
Figure 4. Second Generation Picture
Figure 5. Third Generation Picture
Figure 6. Neuroleptics Sales Market Share by Application in 2018
Figure 7. Schizophrenia Picture
Figure 8. Bipolar Disorder Picture
Figure 9. Unipolar Depression Picture
Figure 10. Dementia Picture
Figure 11. Others Picture
Figure 12. Global Neuroleptics Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Neuroleptics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Neuroleptics Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Neuroleptics Sales Market Share by Manufacturer in 2019
Figure 33. Global Neuroleptics Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Neuroleptics Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Neuroleptics Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 38. Global Neuroleptics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Neuroleptics Revenue Market Share by Regions (2015-2020)
Figure 40. Global Neuroleptics Revenue Market Share by Regions in 2018
Figure 41. North America Neuroleptics Sales and Growth Rate (2015-2020)
Figure 42. Europe Neuroleptics Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Neuroleptics Sales and Growth Rate (2015-2020)
Figure 44. South America Neuroleptics Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Neuroleptics Sales and Growth Rate (2015-2020)
Figure 46. North America Neuroleptics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Neuroleptics Sales Market Share by Countries (2015-2020)
Figure 48. North America Neuroleptics Sales Market Share by Countries in 2018
Figure 49. North America Neuroleptics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Neuroleptics Revenue Market Share by Countries in 2018
Figure 51. United States Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Canada Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Mexico Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Europe Neuroleptics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Neuroleptics Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Neuroleptics Revenue Market Share by Countries in 2019
Figure 57. Germany Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 58. UK Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 59. France Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Russia Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Italy Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Asia-Pacific Neuroleptics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Neuroleptics Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Neuroleptics Revenue Market Share by Regions 2019
Figure 65. China Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Japan Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Korea Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 68. India Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Southeast Asia Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 70. South America Neuroleptics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Neuroleptics Sales Market Share by Countries in 2019
Figure 72. South America Neuroleptics Revenue Market Share by Countries in 2019
Figure 73. Brazil Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Argentina Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Middle East and Africa Neuroleptics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Neuroleptics Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Neuroleptics Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Neuroleptics Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Egypt Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Turkey Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 82. South Africa Neuroleptics Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Global Neuroleptics Sales and Growth Rate (2021-2025) (K MT)
Figure 84. Global Neuroleptics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Neuroleptics Market Forecast (2021-2025) (K MT)
Figure 86. Europe Sales Neuroleptics Market Forecast (2021-2025) (K MT)
Figure 87. Asia-Pacific Sales Neuroleptics Market Forecast (2021-2025) (K MT)
Figure 88. South America Sales Neuroleptics Market Forecast (2021-2025) (K MT)
Figure 89. Middle East & Africa Sales Neuroleptics Market Forecast (2021-2025) (K MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
神経遮断薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Neuroleptics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neuroleptics market report provi…- 電荷発生材料（CGM）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Charge Generation Materials (CGM) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 次世代視覚化およびナビゲーションシステムの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Next-Generation Visualization and Navigation Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 20…
- 精製水生成システムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Purified Water Generation System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 抗精神病薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antipsychotics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antipsychotics market report p…